| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4781643
Max Phase: Preclinical
Molecular Formula: C18H22N6OS
Molecular Weight: 370.48
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: N#Cc1ncc2c(=O)nc(N3CCN(CC4CCCCC4)CC3)sc2n1
Standard InChI: InChI=1S/C18H22N6OS/c19-10-15-20-11-14-16(25)22-18(26-17(14)21-15)24-8-6-23(7-9-24)12-13-4-2-1-3-5-13/h11,13H,1-9,12H2
Standard InChI Key: CTNUZXOMELJLQK-UHFFFAOYSA-N
Associated Targets(non-human)
FAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase 247 Activities
Mycobacterium tuberculosis 203094 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 370.48 | Molecular Weight (Monoisotopic): 370.1576 | AlogP: 2.02 | #Rotatable Bonds: 3 |
| Polar Surface Area: 86.01 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 7.55 | CX LogP: 3.23 | CX LogD: 2.85 |
| Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.82 | Np Likeness Score: -1.71 |
References
| 1. Liu L,Kong C,Fumagalli M,Savková K,Xu Y,Huszár S,Sammartino JC,Fan D,Chiarelli LR,Mikušová K,Sun Z,Qiao C. (2020) Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents., 208 [PMID:32898793] [10.1016/j.ejmech.2020.112773] |
Source
Source(1):